Gold Acyclic Diaminocarbene Complexes as Selective and Potent Agents for Multitarget Cancer Therapy
Inorganic Chemistry · 19.05.2025 · 64 (19) · 9608-9620
DOI: 10.1021/acs.inorgchem.5c00579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, online erschienen am 05.05.2025. Verfasst von María Gil-Moles und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea (ISQCH) CSIC-Universidad de Zaragoza, Zaragoza 50009, Spain. Hauptthemen laut MEDLINE: Antineoplastic Agents, Gold Compounds, Amines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gobierno de Arag?n, Ministerio de Ciencia, Innovaci?n y Universidades.
Abstract (Originalsprache)
Gold acyclic diaminocarbene (ADC) complexes represent a promising, yet underexplored, class of chemotherapeutics. ADCs offer superior flexibility and stronger sigma donation compared with traditional N-heterocyclic carbenes, making them ideal ligands for stable gold-based drugs. In this study, a series of gold ADC complexes were synthesized via the nucleophilic addition of amines to [AuCl(CNCy)], yielding three structural families: gold-chloride-ADC (chiral and achiral), bis(carbene), and thiolate-gold-ADC complexes. Extensive characterization, including X-ray diffraction, revealed noncovalent interactions, such as hydrogen bonding and aurophilic contacts, that significantly shape their molecular architecture. These complexes exhibit potent cytotoxicity (IC50 in submicromolar) against drug-resistant cancer cell lines (A549, HCT116 WT, Jurkat, MiaPaca2), with some showing high selectivity toward cancer cells over healthy lymphocytes (selectivity index up to 74). Mechanistic investigations indicate that they disrupt mitochondrial function, elevate reactive oxygen species (ROS), and, in the case of bis(carbene) species, bind DNA. Apoptosis is induced at low concentrations, while higher doses trigger alternative death pathways. Notably, they also strongly inhibit thioredoxin reductase (TrxR), comparable in potency to auranofin. The combination of ROS induction, DNA interaction, mitochondrial disruption, and TrxR inhibition highlights the multitargeted anticancer potential of gold-ADC complexes and supports their further development as selective and effective chemotherapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea (ISQCH) CSIC-Universidad de Zaragoza, Zaragoza 50009, Spain.
- Departamento de Bioquímica y Biología Celular, Universidad de Zaragoza, Zaragoza 50009, Spain.
ORCID-Profile: M Concepción Gimeno
Förderung
- Gobierno de Arag?n
- Ministerio de Ciencia, Innovaci?n y Universidades
Zitieren
APA
Gil-Moles, M., Aliaga-Lavrijsen, M., Montanel-Pérez, S., Marzo, I., Villacampa, M. D., & Gimeno, M. C. (2025). Gold Acyclic Diaminocarbene Complexes as Selective and Potent Agents for Multitarget Cancer Therapy. Inorganic Chemistry, 64(19), 9608-9620. https://doi.org/10.1021/acs.inorgchem.5c00579
Vancouver
Gil-Moles M, Aliaga-Lavrijsen M, Montanel-Pérez S, Marzo I, Villacampa MD, Gimeno MC. Gold Acyclic Diaminocarbene Complexes as Selective and Potent Agents for Multitarget Cancer Therapy. Inorganic Chemistry. 2025;64(19):9608-9620. doi:10.1021/acs.inorgchem.5c00579
BibTeX
@article{GilMoles2025,
author = {Gil-Moles, María and Aliaga-Lavrijsen, Melanie and Montanel-Pérez, Sara and Marzo, Isabel and Villacampa, M Dolores and Gimeno, M Concepción},
title = {Gold Acyclic Diaminocarbene Complexes as Selective and Potent Agents for Multitarget Cancer Therapy},
journal = {Inorganic Chemistry},
year = {2025},
volume = {64},
number = {19},
pages = {9608--9620},
doi = {10.1021/acs.inorgchem.5c00579}
}
EUVIMED